The article discusses modern approaches to the treatment of atherogenic patients, provides data on the effectiveness of new hypolipidemic drugs and discusses the role of intensive statin use regimes at the modern stage of the lipid-lowering therapy. Evidence is provided on the effectiveness of the use of rosuvastatin to reduce blodo LDL-cholesterol and to reduce the risk of cardiovascular disease complications caused by atherosclerosis
Statin is one of the most commonly prescribed medicines in the developed World. In 2016, statin was ...
ABSTRACT Statins are an established class of drugs with proven efficacy in cardiovascular risk redu...
Several studies have reported a significant reduction in morbidity and mortality in patients with ac...
The introduction of statins has drastically changed the treatment and prevention of atherosclerotic ...
This article discusses the problems of adequate therapy for dys-lipidemia in patients with high and ...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Primary and secondary prevention of cardiovascular complications (CVC) has been one of the key areas...
<p>Early and aggressive treatment of patients with risk factors and clinically manifest cardiovascul...
AbstractSignificant advances in the management of cardiovascular disease have been made possible by ...
Coronary heart disease (CHD) is a major cause of morbidityand mortality. Recent evidence supports th...
SummaryStatins have been shown to reduce cardiovascular events across a broad spectrum of patients a...
This review deals with the necessary and relevant measures for primary and secondary prevention of c...
In the past years, statins have emerged as the most important class of lipid lowering agents. Throug...
The article reviews current approaches to primary prevention of cardiovascular events and risk-benef...
Statins clearly confer substantial benefit in people with established cardiovascular (CV) disease. I...
Statin is one of the most commonly prescribed medicines in the developed World. In 2016, statin was ...
ABSTRACT Statins are an established class of drugs with proven efficacy in cardiovascular risk redu...
Several studies have reported a significant reduction in morbidity and mortality in patients with ac...
The introduction of statins has drastically changed the treatment and prevention of atherosclerotic ...
This article discusses the problems of adequate therapy for dys-lipidemia in patients with high and ...
The explosion of medical knowledge and the importance and real reductions in adverse cardiovascular ...
Primary and secondary prevention of cardiovascular complications (CVC) has been one of the key areas...
<p>Early and aggressive treatment of patients with risk factors and clinically manifest cardiovascul...
AbstractSignificant advances in the management of cardiovascular disease have been made possible by ...
Coronary heart disease (CHD) is a major cause of morbidityand mortality. Recent evidence supports th...
SummaryStatins have been shown to reduce cardiovascular events across a broad spectrum of patients a...
This review deals with the necessary and relevant measures for primary and secondary prevention of c...
In the past years, statins have emerged as the most important class of lipid lowering agents. Throug...
The article reviews current approaches to primary prevention of cardiovascular events and risk-benef...
Statins clearly confer substantial benefit in people with established cardiovascular (CV) disease. I...
Statin is one of the most commonly prescribed medicines in the developed World. In 2016, statin was ...
ABSTRACT Statins are an established class of drugs with proven efficacy in cardiovascular risk redu...
Several studies have reported a significant reduction in morbidity and mortality in patients with ac...